Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin

Neuroscience Letters

Volumn 611, Issue , 2016, Pages 106-111

  Sulakhiya, Kunjbihari ^a   Keshavlal, Gohil Pratik ^a   Bezbaruah, Babul B ^b   Dwivedi, Shubham ^a   Gurjar, Satendra Singh ^a   Munde, Nitin ^a   Jangra, Ashok ^a   Lahkar, Mangala ^b   Gogoi, Ranadeep ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b GAUHATI MEDICAL COLLEGE   (India)

Author keywords

Anxiety; Depression; Esculetin; Lipopolysaccharide; Neuroinflammation; Oxidative stress

Indexed keywords

CORTICOSTERONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; ESCULETIN; GLUTATHIONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; LIPOPOLYSACCHARIDE; UMBELLIFERONE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; DEPRESSION; ELEVATED PLUS MAZE TEST; EXPLORATORY BEHAVIOR; FORCED SWIM TEST; HIPPOCAMPUS; LIPID PEROXIDATION; LONG TERM CARE; MALE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TAIL SUSPENSION TEST; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; MOUSE; PREVENTION AND CONTROL; PSYCHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEPRESSION; HIPPOCAMPUS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA; UMBELLIFERONES;

EID: 84949309810     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.11.031     Document Type: Article

References (31)

1. Santosh P., Venugopl R., Nilakash A.S., Kunjbihari S., Mangala L. Antidepressant activity of methanolic extract of Passiflora foetida leaves in mice. Int. J. Pharm. Pharm. 2011, 3:112-115.
2. Sahoo S., Khess C.R. Prevalence of depression, anxiety, and stress among young male adults in India: a dimensional and categorical diagnoses-based study. J. Nerv. Ment. Dis. 2010, 198:901-904.
3. Mesfin M., Asres K., Shibeshi W. Evaluation of anxiolytic activity of the essential oil of the aerial part of Foeniculum vulgare Miller in mice. BMC Complement. Altern. Med. 2014, 14:310.
4. Sulakhiya K., Kumar P., Jangra A., Dwivedi S., Hazarika N.K., Baruah C.C., Lahkar M. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice. Eur. J. Pharmacol. 2014, 744:124-131.
5. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
6. Vogelzangs N., Beekman A.T., de Jonge P., Penninx B.W. Anxiety disorders and inflammation in a large adult cohort. Transl. Psychiatry 2013, 3:e249.
7. Mello B.S., Monte A.S., McIntyre R.S., Soczynska J.K., Custodio C.S., Cordeiro R.C., Chaves J.H., Vasconcelos S.M., Nobre H.V., Florenco de Sousa F.C., Hyphantis T.N., Carvalho A.F., Macedo D.S. Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J. Psychiatr. Res. 2013, 47:1521-1529.
8. Leonard B.E., Myint A. The psychoneuroimmunology of depression. Hum. Psychopharmacol. 2009, 24:165-175.
9. Bouayed J., Rammal H., Soulimani R. Oxidative stress and anxiety: relationship and cellular pathways. Oxid. Med. Cell. Longev. 2009, 2:63-67.
10. Grases G., Colom M.A., Fernandez R.A., Costa-Bauza A., Grases F. Evidence of higher oxidative status in depression and anxiety. Oxid. Med. Cell. Longev. 2014, 2014. 5 pages.
11. Jangra A., Lukhi M.M., Sulakhiya K., Baruah C.C., Lahkar M. Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice. Eur. J. Pharmacol. 2014, 740:337-345.
12. Salazar A., Gonzalez-Rivera B.L., Redus L., Parrott J.M., O'Connor J.C. Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm. Behav. 2012, 62:202-209.
13. Lacosta S., Merali Z., Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 1999, 818:291-303.
14. Soncini R., de Souza D.F., Neves A.P., Braga D.S., Andrade C.A., Giusti-Paiva A. Dipyrone attenuates acute sickness response to lipopolysaccharide in mice. Neurosci. Lett. 2012, 516:114-118.
15. Surse V.M., Gupta J., Tikoo K. Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats. J. Mol. Endocrinol. 2011, 46:245-254.
16. Anand J.R., Rijhwani H., Malapati K., Kumar P., Saikia K., Lakhar M. Anticancer activity of esculetin via-modulation of Bcl-2 and NF-κB expression in benzo [a] pyrene induced lung carcinogenesis in mice. Biomed. Prev. Nutr. 2013, 3:107-112.
17. Kim K.A., Zhang R., Piao M.J., Ko D.O., Wang Z.H., Chae S.W., Kang S.S., Lee K.H., Kang H.K., Kang H.W., Hyun J.W. Protective effect of esculetin against oxidative stress-induced cell damage via scavenging reactive oxygen species. Acta Pharmacol. Sin. 2008, 29:1319-1326.
18. Witaicenis A., Seito L.N., Di Stasi L.C. Intestinal anti-inflammatory activity of esculetin and 4-methylesculetin in the trinitrobenzenesulphonic acid model of rat colitis. Chem. Biol. Interact. 2010, 186:211-218.
19. Pan S.L., Huang Y.W., Guh J.H., Chang Y.L., Peng C.Y., Teng C.M. Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats. Biochem. Pharmacol. 2003, 65:1897-1905.
20. Fylaktakidou K.C., Hadjipavlou-Litina D.J., Litinas K.E., Nicolaides D.N. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr. Pharm. Des. 2004, 10:3813-3833.
21. Aragon S.M., Benedi J.M., Villar A.M. Effects of the antioxidant (6, 7-dihydroxycoumarin) esculetin on the glutathione system and lipid peroxidation in mice. Gerontology 1997, 44:21-25.
22. Aragon S.M., Villar A., Bened J. Age-dependent effects of esculetin on mood-related behavior and cognition from stressed mice are associated with restoring brain antioxidant status. Prog. Neuropsychopharmacol. Biol. Psychiatry 2016, 64:1-16.
23. Wang C., Pei A., Chen J., Yu H., Sun M.L., Liu C.F., Xu X. A natural coumarin derivative esculetin offers neuroprotection on cerebral ischemia/reperfusion injury in mice. J. Neurochem. 2012, 121:1007-1013.
24. Subramaniam S.R., Ellis E.M. Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease. J. Neurosci. Res. 2013, 91:453-461.
25. Sulakhiya K., Kumar P., Gurjar S.S., Baruah C.C., Hazarika N.K. Beneficial effect of honokiol on lipopolysaccharide induced anxiety-like behaviour and liver damage in mice. Pharmacol. Biochem. Behav. 2015, 132:79-87.
26. Bassi G.S., Kanashiro A., Santin F.M., de Souza G.E.P., Nobre M.J., Coimbra N.C. Lipopolysaccharide-Induced Sickness Behaviour Evaluated in Different Models of Anxiety and Innate Fear in Rats. Basic Clin. Pharmacol. Toxicol. 2012, 110:359-369.
27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
28. Sah S.P., Tirkey N., Kuhad A., Chopra K. Effect of quercetin on lipopolysaccharide induced-sickness behavior and oxidative stress in rats. Indian J. Pharmacol. 2011, 43:192-196.
29. Hong S.H., Jeong H.K., Han M.H., Park C., Choi Y.H. Esculetin suppresses lipopolysaccharide-induced inflammatory mediators and cytokines by inhibiting nuclear factor-kappa B translocation in RAW 264.7 macrophages. Mol. Med. Rep. 2014, 10:3241-3246.
30. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012, 36:764-785.
31. Chung E.S., Chung Y.C., Bok E., Baik H.H., Park E.S., Park J.Y., Yoon S.H., Jin B.K. Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress. Brain Res. 2010, 1363:143-150.